Lotus Pharmaceutical Co., Ltd. (TPE:1795)
Taiwan · Delayed Price · Currency is TWD 193.00
+1.00 (0.52%)
Sep 3, 2025, 2:38 PM CST
Lotus Pharmaceutical Market Cap
Lotus Pharmaceutical has a market cap or net worth of 50.76 billion as of September 2, 2025. Its market cap has decreased by -25.05% in one year.
Market Cap
50.76B
Enterprise Value
58.26B
Revenue
19.12B
Ranking
n/a
PE Ratio
10.44
Stock Price
193.00
Market Cap Chart
Since August 12, 2014, Lotus Pharmaceutical's market cap has increased from 9.19B to 50.76B, an increase of 452.44%. That is a compound annual growth rate of 16.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2025 | 50.76B | -29.04% |
| Dec 31, 2024 | 71.52B | -0.57% |
| Dec 29, 2023 | 71.94B | 11.59% |
| Dec 30, 2022 | 64.46B | 152.11% |
| Dec 30, 2021 | 25.57B | 30.27% |
| Dec 31, 2020 | 19.63B | -29.79% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 326.49B |
| PharmaEssentia | 165.47B |
| Bora Pharmaceuticals Co., LTD. | 90.22B |
| Oneness Biotech | 33.48B |
| Lumosa Therapeutics | 32.18B |
| Polaris Group | 30.09B |
| Center Laboratories | 26.43B |
| Pegavision | 24.38B |